viernes, 19 de abril de 2024

Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval MAY 9, 2024

https://www.fda.gov/drugs/news-events-human-drugs/redesigned-pre-submission-meetings-gdufa-iii-benefits-anda-submission-and-approval-05092024?utm_medium=email&utm_source=govdelivery

No hay comentarios: